Ph.D. in Pharmaceutical Sciences from the University of Campinas (UNICAMP), Brazil. Holds a Bachelor's degree in Chemistry (2017) from the same institution. Participated in an international exchange program (Science Without Borders Undergraduate Sandwich Program) at the University at Albany State University of New York (20132014), where she gained experience in cell biology, specifically in the study of nucleic acid structure-function and proteinnucleic acid complexes involved in infectious diseases. This research was conducted at the RNA Institute (University at Albany). She has experience in microbial natural products chemistry, with a focus on untargeted metabolomics analyses. She also has extensive experience in culturing cancer cells and investigating the mechanism of action of phytoprogestins as potential therapies for ovarian cancer. She completed her first postdoctoral fellowship at the Burdette Lab, College of Pharmacy, University of Illinois Chicago (UIC), focusing on natural products and cancer. Subsequently, she conducted her second postdoctoral research at the Lipid and Metabolism Laboratory of the Heart Institute (InCor-HCFMUSP), where she currently works as a researcher. Her current research focuses on lipoprotein metabolism and the use of lipid-based nanoparticles for drug delivery in the treatment of degenerative diseases such as cancer and cardiovascular disorders. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The production of nanoparticles, named by LDE, in our laboratory is already well standardized for some chemotherapeutics, such as paclitaxel, docetaxel, daunorubicin, etoposide and methotrexate. The modification of the chemical structure of the drug by esterification reactions is necessary to increase lipophilicity and ensure the incorporation of these drugs into the nanoparticles, thus o…
Over the past three decades microorganisms have been studied as a promising source of bioactive molecules opening up wide possibilities for the use in the pharmaceutical industry related to the treatment of several diseases. Recent researches indicate that a significant number of new bioactive natural products are products derived from interactions between these organisms with their respe…
In the last three decades, microorganisms have been studied as a promising source of bioactive molecules with wide possibilities of use in the pharmaceutical industry in the treatment of various diseases. In this work, different phytopathogenic fungi will be studied in relation to the production of bioactive secondary metabolites, being 4 strains of the genus Penicillium. All strains will…
According to statistical data from 1946 to Sep/2019, there are 13.5% and 25.1% of anticancer drugs originating and derived from natural products, respectively. Epicoccum sp. is a genus of ubiquitous ascomycetes belongs to the Didymellaceae family and known to produce a wide variety of biologically and chemically useful compounds, such as polyketides, diketopiperazines, polyketide hybrids …
| 1 / 1 | Ongoing scholarships in Brazil |
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 4 / 4 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID